Cara Therapeutics Inc. (CARA)
NASDAQ: CARA
· Real-Time Price · USD
5.32
-0.14 (-2.56%)
At close: Apr 15, 2025, 3:59 PM
Cara Therapeutics Revenue
Cara Therapeutics reported an annual revenue of $7.14M, reflecting a -65.96% growth. For the quarter ending June 30, 2025, Cara Therapeutics generated $0 in revenue.
Revenue (ttm)
7.14M
Revenue Growth
-65.96%
Price / Sales Ratio
117.38
Revenue / Employee
713.7K
Employees
10
Market Cap
8.11M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 7.14M | -65.96% |
| Dec 31, 2023 | 20.97M | -49.92% |
| Dec 31, 2022 | 41.87M | +81.81% |
| Dec 31, 2021 | 23.03M | -82.95% |
| Dec 31, 2020 | 135.08M | +579.28% |
| Dec 31, 2019 | 19.89M | +47.64% |
| Dec 31, 2018 | 13.47M | +1378.49% |
| Dec 31, 2017 | 911K | +959.30% |
| Dec 31, 2016 | 86K | -97.74% |
| Dec 31, 2015 | 3.8M | +19.70% |
| Dec 31, 2014 | 3.18M | -73.45% |
| Dec 31, 2013 | 11.96M | +905.38% |
| Dec 31, 2012 | 1.19M | +Infinity% |
| Dec 31, 2011 | 0 | n/a |